Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Future Med Chem. 2012 Feb;4(2):205–226. doi: 10.4155/fmc.11.195

Table 10.

Binding and intracerebroventricular antinociception as a function of helix stability: glucopeptides.

Compound Message sequence Link Helical address sequence Ki (nM)
A50
δ receptor μ receptor κ receptor Intracerebroventricular (nmol)
41* YtFGL P NLBEKBLKS*L-NH2 11 9.1 6.9 1.13

42*/33 YtFGL P NLBEKALKS*L-NH2 3.6 2.3 2.6 0.58

43* YtFGL P NLAEKBLKS*L-NH2 14 6.1 12 1.46

44* YtFGL P NLAEKALKS*L-NH2 7.9 6.2 8.9 1.44

45* YtFGL P NLAEKGLKS*L-NH2 6.3 2.2 6.3 1.47

46* YtFGL P NLGEKALKS*L-NH2 5.7 2.9 11 2.54

47* YtFGL P NLGEKGLKS*L-NH2 7.1 3.5 4.4 2.12

S = OH; S* = Glc; S** = Lact.

P: Proline; S: Serine.

HHS Vulnerability Disclosure